反应条件
1: Et3N / 100 °C 2: 1.) Et3N, 4-dimethylaminopyridine, 2.) triethylammonium hydrogen carbonate / 1.) CH3CN, 24 h, 2.) CH3CN, 24 h View Scheme
参考文献
METABASIS THERAPEUTICS, INC.; BOYER, Serge H.; ERION, Mark D.; ITO, Bruce; JACINTHO, Jason
Patent: WO2011/38207 A1, 2011 ;